Drug intelligence / Profile preview

Shen'an decoction

Development stage: Unknown
Lead developer: Hospital Affiliated to Changchun University of Traditional Chinese Medicine
Administration: Oral

Overview

Shen'an decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Affiliated Hospital of Changchun University of Chinese Medicine. It is primarily investigated for the treatment of diabetic nephropathy (DN) in patients with type 2 diabetes mellitus. The decoction is intended to improve renal function and reduce proteinuria, potentially by modulating inflammatory and fibrotic pathways associated with chronic kidney damage in diabetic patients. It has been evaluated in randomized controlled clinical trials in China, where its efficacy and safety are compared against standard-of-care treatments such as the angiotensin II receptor blocker valsartan.

Other names: Shenan decoction

Beyond the preview

Go deeper on Shen'an decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shen'an decoction.

Explore the full profile